Adoptive cell therapy with tumor-infiltrating lymphocytes in combination with nivolumab in patients with advanced melanoma

Autor: D. König, B. Kasenda, M. Sandholzer, A. Chirindel, A. Zingg, R. Ritschard, H. Thut, K. Glatz, E.A. Kappos, D. Schaefer, C. Kettelhack, J. Passweg, K. Baur, A. Holbro, A. Buser, D. Lardinois, L.T. Jeker, N. Khanna, F. Stenner, M.S. Matter, N. Rodrigues Mantuano, M. Binder, A. Zippelius, H. Läubli

Publikováno v: Immuno-Oncology and Technology, Vol 24, Iss , Pp 100728- (2024)

Background: Adoptive cell therapy (ACT) with tumor-infiltrating lymphocytes (TIL) is a personalized immunotherapy. The efficacy of TIL-ACT has been demonstrated prospectively in patients with advanced melanoma but is not limited to melanoma patients.

Externí odkaz: https://doaj.org/article/a77a15df7af5480ea93dda0ce4aa25e6

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

An update on the management of sporadic desmoid-type fibromatosis:a european consensus initiative between sarcoma patients euronet (spaen) and european organization for research and treatment of cancer (eortc)/soft tissue and bone sarcoma group (stbsg)

Autor: B. Kasper, C. Baumgarten, J. Garcia, S. Bonvalot, R. Haas, F. Haller, P. Hohenberger, N. Penel, C. Messiou, W.T. van der Graaf, A. Gronchi, S. Bauer, J.Y. Blay, F. van Coevorden, P. Dileo, H.R. Dürr, M. Fiore, V. Grünwald, R. Jones, I. Judson, C. Kettelhack, K. Kopeckova, A. Lazar, L.H. Lindner, J. Martin-Broto, P. Rutkowski, S. Stacchiotti, E. Stoeckle, C. Valverde, K. Verhoef, E. Wardelmann, M. Wartenberg

Publikováno v: Annals of Oncology
Annals of Oncology, Elsevier, 2017, Annals of oncology official journal of the European Society for Medical Oncology, 28, pp.2399-2408. ⟨10.1093/annonc/mdx323⟩
Digital.CSIC. Repositorio Institucional del CSIC
instname
Annals of Oncology, 28, 2399-2408
Annals of Oncology, 2017, Annals of oncology official journal of the European Society for Medical Oncology, 28, pp.2399-2408. ⟨10.1093/annonc/mdx323⟩
Annals of Oncology, 28, 10, pp. 2399-2408

Desmoid-type fibromatosis is a rare and locally aggressive monoclonal, fibroblastic proliferation characterized by a variable and often unpredictable clinical course. Currently, there is no established or evidence-based treatment approach available f

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fe5adec7b93efaa9f3e0c38f39e552b
http://hdl.handle.net/20.500.12210/17223

The Microbiota and Microbiome in COVID-19 in Adults and Children and Potential Therapeutic Interventions: A Review.

Autor: Benitez-Baez, Miriam Jaqueline¹, Angulo-Varela, Enrique Alonso², Aispuro-Heredia, Jarianth del Rosario², Vázquez-Noriega, Edgar Gabino², Karam-León, Alejandra¹, Angulo-Zamudio, Uriel Alberto², Canizalez-Roman, Adrian^2,3, León-Sicairos, Nidia^2,4 nidialeon@uas.edu.mx

Publikováno v: Trends in Sciences. Nov2024, Vol. 21 Issue 11, p1-27. 27p.